DOI QR코드

DOI QR Code

Hypothermia Regulates Insulin-like Growth Factor 1 Gene Expression in PC12 Cells

  • Yoo, Bo-Kyung (Department of Anatomy & Cell Biology, College of Medicine, Chungnam National University) ;
  • Kwon, Kisang (Department of Biomedical Laboratory Science, College of Health & Welfare, Kyungwoon University) ;
  • Lee, Eun Ryeong (Department of Biomedical Laboratory Science, College of Health & Welfare, Kyungwoon University) ;
  • Kim, Seung-Whan (Department of Emergency Medicine, Chungnam National University Hospital) ;
  • Yu, Kweon (Korea Research Institute of Bioscience & Biotechnology) ;
  • Kwon, O-Yu (Department of Anatomy & Cell Biology, College of Medicine, Chungnam National University)
  • Received : 2016.10.14
  • Accepted : 2017.02.09
  • Published : 2017.03.31

Abstract

In this study, we evaluated the effects of various hypothermic conditions ($32^{\circ}C$), including lithium chloride treatment, on insulin-like growth factor 1 (IGF-1) gene expression in PC12 cells. The results show that short-term hypothermic treatment (<1 day) resulted in relatively higher IGF-1 gene expression than did longer-term treatment (>1 day). Repeated switching between normal temperature and hypothermia every 2 h increased IGF-1 gene expression approximately 3-4-fold. These findings indicate that hypothermia dynamically regulates IGF-1 gene expression. This study could be helpful for the development of treatment and diagnostic strategies for ischemia.

Keywords

References

  1. Al-Astal HI, Massad M, AlMatar M, Ekal H. Cellular functions of RNA-binding motif protein 3 (RBM3): Clues in hypothermia, cancer biology and apoptosis. Protein & Peptide Letters. 2016. 23: 828-835. https://doi.org/10.2174/0929866523666160628090340
  2. American Heart Association. 2005 American Heart Association (AHA) guidelines for cardiopulmonary resuscitation (CPR) and emergency cardiovascular care (ECC) of pediatric and neonatal patients: pediatric basic life support. Pediatrics. 2006. 117: e989-1004. https://doi.org/10.1542/peds.2006-0219
  3. Bretteville A, Marcouiller F, Julien C, El Khoury NB, Petry FR, Poitras I, Mouginot D, Levesque G, Hebert SS, Planel E. Hypothermia-induced hyperphosphorylation: a new model to study tau kinase inhibitors. Scientific Reports 2012: 480.
  4. Cheng G, Kim MJ, Jia G, Agrawal DK. Involvement of chloride channels in IGF-I-induced proliferation of porcine arterial smooth muscle cells. Cardiovascular Research. 2007. 73: 198-207. https://doi.org/10.1016/j.cardiores.2006.10.012
  5. Daughaday WH, Hall K, Raben MS, Salmon WD Jr, van den Brande JL, van Wyk JJ. Somatomedin: a proposed designation for the sulfation factor. Nature. 1972. 235: 107. https://doi.org/10.1038/235107a0
  6. Imataka G, Arisaka O. Brain hypothermia therapy for childhood acute encephalopathy based on clinical evidence. Experimental and Therapeutic Medicine. 2015. 10: 1624-1626. https://doi.org/10.3892/etm.2015.2760
  7. Lee YJ, Han HJ. Troglitazone ameliorates high glucose-induced EMT and dysfunction of SGLTs through PI3K/Akt, GSK-$3{\beta}$, Snail1, and ${\beta}$-catenin in renal proximal tubule cells. American Journal of Physiology-Renal Physiology. 2010. 298: F1263-1275. https://doi.org/10.1152/ajprenal.00475.2009
  8. Meffre D, Massaad C, Grenier J. Lithium chloride stimulates PLP and MBP expression in oligodendrocytes via Wnt/${\beta}$-catenin and Akt/CREB pathways. Neuroscience. 2015. 284: 962-971. https://doi.org/10.1016/j.neuroscience.2014.10.064
  9. Mullis PE, Patel MS, Brickell PM, Hindmarsh PC, Brook CG. Growth characteristics and response to growth hormone therapy in patients with hypochondroplasia: genetic linkage of the insulin-like growth factor I gene at chromosome 12q23 to the disease in a subgroup of these patients. Clinical Endocrinology. 1991. 34: 265-274. https://doi.org/10.1111/j.1365-2265.1991.tb03765.x
  10. Rinderknecht E, Humbel RE. Polypeptides with nonsuppressible insulin-like and cell-growth promoting activities in human serum: isolation, chemical characterization, and some biological properties of forms I and II. Proceedings of the National Academy of Sciences. 1976. 73: 2365-2369. https://doi.org/10.1073/pnas.73.7.2365
  11. Rinderknecht E, Humbel RE. The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. The Journal of Biological Chemistry. 1978. 253: 2769-2776.
  12. Rotwein P. Structure, evolution, expression and regulation of insulinlike growth factors I and II. Growth Factors. 1991. 5: 3-18. https://doi.org/10.3109/08977199109000267
  13. Salmon WD Jr, Daughaday W. A hormonally controlled serum factor which stimulates sulfate incorporation by cartilage in vitro. Journal of Laboratory and Clinical Medicine. 1957. 49: 825-836.
  14. Sturtevant J. Applications of differential-display reverse transcription-PCR to molecular pathogenesis and medical mycology. Clinical Microbiology Reviews. 2000. 13: 408-427. https://doi.org/10.1128/CMR.13.3.408-427.2000
  15. Wardlaw JM, Murray V, Berge E, del Zoppo G, Sandercock P, Lindley RL, Cohen G. Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis. Lancet. 2012. 379: 2364-2372. https://doi.org/10.1016/S0140-6736(12)60738-7
  16. Yenari MA, Han HS. Neuroprotective mechanisms of hypothermia in brain ischaemia. Nature Reviews Neuroscience. 2012. 13: 267-278. https://doi.org/10.1038/nrn3174
  17. Yenari MA, Zhao H, Giffard RG, Sobel RA, Sapolsky RM, Steinberg GK. Gene therapy and vhypothermia for stroke treat- ment. Annals of the New York Academy of Sciences. 2003. 993: 54-68. https://doi.org/10.1111/j.1749-6632.2003.tb07511.x